Is AI ready to take over your prescriptions? Doctors are wary of Utah’s automated refill program
Is AI ready to take over your prescriptions? Doctors are wary of Utah’s automated refill program
A New Era in Healthcare: Utah’s AI Prescription Refill Pilot
Is AI ready to take over – In early 2026, Utah quietly introduced a prescription refill initiative that has ignited a major discussion about the integration of artificial intelligence into medical practice. The program, powered by an AI chatbot named Doctronic, enables residents to obtain medication refills online without visiting a doctor. This marks a pivotal shift in healthcare delivery, promising greater convenience for patients. However, it has also sparked unease among medical professionals, legal experts, and public health advocates who question whether AI can safely assume responsibilities traditionally reserved for licensed practitioners.
The Debate Over AI’s Role in Medicine
The pilot has exposed critical questions about AI’s growing influence in healthcare. Central to the controversy is the longstanding rule that only licensed medical professionals can prescribe medications. While proponents argue that these laws should evolve to accommodate technological advancements, critics warn of potential risks. Dr. Eric Bressman, a University of Pennsylvania physician, highlights the significance of the program: “We have crossed a threshold in terms of giving something that is not human a medical license, whether or not we want to call it that.” He and others emphasize that AI should be held to the same high standards as human doctors, who undergo years of education and training before practicing.
Regulatory Sandboxes and AI Oversight
The program’s implementation was made possible through Utah’s “regulatory sandbox” policy, which allows state officials to temporarily waive certain laws for AI companies testing innovative solutions. Currently, Doctronic operates under a five-member board of AI specialists, none of whom are physicians. This board claims to have established multiple safeguards, though its lack of medical expertise has raised eyebrows. During the initial phase, human doctors review all refill orders, but the company plans to transition to full automation soon.
Concerns from Medical Professionals
Dr. Alan Smith, head of Utah’s medical licensing board, expressed frustration after learning about the program in January. In a March letter to state officials, 11 board members called for an immediate pause, citing the risks of automated prescriptions. They highlighted the potential for errors in medications with side effects or drug interactions. “We were essentially told: ‘Yes this is going on. And no, you don’t have a say in it,’” Smith said, noting he was speaking only on behalf of himself. The board’s concerns reflect broader anxieties about the erosion of human oversight in critical medical decisions.
Federal vs. State Regulation: A Lingering Dispute
The program has also highlighted a divide between federal and state regulatory frameworks. While medical professionals are typically governed by state licensing boards, the Food and Drug Administration (FDA) is responsible for overseeing technologies that directly affect patient care. Some experts argue that Doctronic’s AI has crossed into this domain, warranting federal scrutiny. Doctronic executives, however, downplay this, stating their focus is on improving patient access rather than navigating complex regulations. “Our goal here is really just to meet patients where they need healthcare,” said Dr. Adam Oskowitz, a co-founder of the company.
How the Refill Process Works
Patients in Utah can access Doctronic’s platform via a dedicated website. After verifying their identity, the AI chatbot prompts users to provide details about their prescriptions and medical history. It cross-references this information with a national pharmacy database to confirm valid prescriptions. If no issues are detected, the AI automatically approves the refill and sends it to a local pharmacy. For more complex cases, the chatbot connects the user to a human doctor affiliated with Doctronic’s telehealth services.
Promise and Peril: The Road Ahead
Oskowitz envisions a future where AI handles routine tasks like ordering tests and analyzing results, allowing doctors to manage more patients efficiently. This could address the growing strain on healthcare systems, where practitioners often face overwhelming workloads. However, the program’s success depends on proving its reliability. The board of AI specialists asserts that safeguards are in place, but doctors worry about the absence of direct human evaluation.
Expanding AI’s Reach: Other States and Legislative Moves
Utah is not the only state experimenting with AI in healthcare. Texas and Wyoming have also relaxed regulations to support similar initiatives. Meanwhile, lawmakers in Iowa, Idaho, and other states are drafting legislation to formally license AI medical services. Many of these bills draw inspiration from the Cicero Institute, a nonprofit think tank founded by Joe Lonsdale, co-founder of Palantir Technologies. The institute advocates for AI integration, arguing that existing laws are outdated and need modernization.
The Economic Impact on Healthcare Workers
Resistance to AI in medicine is not solely technical. Many doctors and health workers express economic concerns, fearing that automation could reduce their roles and income. Cicero’s research underscores this, noting that the shift could disrupt traditional career paths. Despite these fears, the program’s proponents believe the benefits outweigh the risks, pointing to improved patient convenience and efficiency in healthcare delivery.
Testing the Waters: A Cautionary Experiment
The Utah program serves as a test case for AI’s potential in medicine. While the AI specialists overseeing the initiative claim to have implemented robust checks, the process remains a point of contention. Critics argue that automated refills could lead to overlooked drug interactions or misdiagnosed conditions, especially in cases requiring nuanced judgment. Yet, supporters maintain that the system is designed to minimize errors through rigorous data analysis and human review.
Broader Implications for Medical Practice
As AI continues to permeate healthcare, the Utah experiment raises questions about the future of medical licensing and decision-making. If AI can assume prescription responsibilities, it may challenge the traditional model where human expertise is paramount. This could lead to a redefinition of what it means to be a “licensed medical professional” in an increasingly digital world. Experts like Bressman caution that while AI can enhance efficiency, it must not compromise patient safety.
A Balancing Act: Innovation and Responsibility
The debate over Doctronic underscores the need for a balance between innovation and responsibility. While the program’s convenience is undeniable, its implications for medical practice are profound. The state’s regulatory sandbox provides a flexible framework for testing AI’s capabilities, but broader adoption may require federal intervention. As more states explore similar initiatives, the question remains: How do we ensure that AI tools are not only efficient but also trustworthy in matters of life and health?
Looking to the Future: AI in Medicine
For now, the Utah program is a modest step toward a larger transformation. If successful, it could pave the way for AI to handle more complex tasks, from diagnostics to treatment plans. However, this transition will depend on resolving the legal, ethical, and economic challenges that have emerged. As the technology evolves, so too must the regulations that govern its use, ensuring that patients remain at the center of care.
